Premium
Do Anticoagulants or Antiplatelet Drugs Have a Role in Treating Heart Failure in the Absence of Atrial Fibrillation?
Author(s) -
Gouda P,
Ezekowitz J A
Publication year - 2013
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2013.133
Subject(s) - medicine , atrial fibrillation , clinical pharmacology , heart failure , cardiology , stroke (engine) , intensive care medicine , risk stratification , sinus rhythm , pharmacology , mechanical engineering , engineering
Patients with atrial fibrillation (AF) and heart failure (HF) are at risk for stroke, and progress in anticoagulation has led to new options for these patients. Patients in sinus rhythm may benefit from antiplatelet agents or anticoagulants, but much work remains to establish efficacy and safety. Additional progress is needed, including better tools for risk stratification and clarity regarding the need for antiplatelet agents in combination with anticoagulants for those with other vascular diseases. Clinical Pharmacology & Therapeutics (2013); 94 4, 435–438. doi: 10.1038/clpt.2013.133